Generated: April 30, 2017
|Title:||Controlled release hydrocodone formulations|
|Abstract:||A solid oral controlled-release dosage form of hydrocodone is disclosed, the dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof, and controlled release material.|
|Inventor(s):||Oshlack; Benjamin (New York, NY), Huang; Hua-Pin (Englewood Cliffs, NJ), Masselink; John K. (Old Tappan, NJ), Tonelli; Alfred P. (Congers, NY)|
|Assignee:||Purdue Pharma, L.P. (Stamford, CT)|
1. cited by applicant
Summons to attend oral proceedings issued on Jun. 5, 2013, in connection with European Patent Application No. 10179086.3. cited by applicant .
Claims pending in U.S. Appl. No. 13/833,263 on Nov. 19, 2013. cited by applicant .
Claims pending in U.S. Appl. No. 14/094,968 on Dec. 9, 2013. cited by applicant .
Claims pending in U.S. Appl. No. 13/833,263 on Dec. 9, 2013. cited by applicant.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.